Clinical efficacy of surgically assisted transjugular intrahepatic portosystemic shunt for cavernous transformation of portal vein

Table 1 A detailed comparison of surgically assisted transjugular intrahepatic portosystemic shunt with other surgically assisted portosystemic shunt

	Intraoperative risk	Portal thrombosis	Study purpose	Comparison
SATIPS	Medium	CTPV	To study the efficacy and feasibility of SATIPS in the treatment of CTPV
Surgically assisted portosystemic shunt (Grigory Rozenblit)	Medium	None	To report a new technology	It reported the technology, but did not study the clinical efficacy
Surgically assisted portosystemic shunt (Hamed Jalaeian)	Medium	None	To study the effect of surgically assisted TIPS in the treatment of portal hypertension without portal vein thrombosis	The patients had no portal vein thrombosis, and routine TIPS did not require surgical intervention. To date, the study has limited significance
TEPS	Hard	CTPV	To study the effect of TEPS on CTPV	The risk of TEPS puncture is high, the risk of intraoperative bleeding is high, and the long-term stability of postoperative stent remains to be observed

SATIPS: Surgically assisted transjugular intrahepatic portosystemic shunt; CTPV: Cavernous transformation of the portal vein; TIPS: Transjugular intrahepatic portosystemic shunt; TEPS: Transjugular extrahepatic portosystemic shunt.